Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

[1]  R. Califf,et al.  Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. , 2000, The American journal of cardiology.

[2]  W. Weaver,et al.  Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction , 2005, Current controlled trials in cardiovascular medicine.

[3]  A. Jaffe,et al.  Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.

[4]  M. Pfisterer,et al.  Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. , 1996, European heart journal.

[5]  G. Stone,et al.  Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[6]  N. Weissman,et al.  A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). , 2008, American heart journal.

[7]  H. Katus,et al.  Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. , 2006, Journal of the American College of Cardiology.

[8]  R. Ideker,et al.  Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. , 1984, Circulation.

[9]  S. Tsung.  Several conditions causing elevation of serum CK-MB and CK-BB. , 1981, American journal of clinical pathology.

[10]  S. Plein,et al.  Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction , 2006, Heart.

[11]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[12]  A. Pupi,et al.  Gated SPECT evaluation of the relationship between admission troponin I, myocardial salvage, and functional recovery in acute myocardial infarction treated by abciximab and early primary angioplasty. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A. Sinusas,et al.  New hybrid count- and geometry-based method for quantification of left ventricular volumes and ejection fraction from ECG-gated SPECT: methodology and validation , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  B. Pau,et al.  Release kinetics of serum cardiac troponin I in ischemic myocardial injury. , 1996, Clinical biochemistry.

[15]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[16]  O. Morel,et al.  Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. , 2006, American heart journal.

[17]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[18]  P. Ohlmann,et al.  Troponin I concentrations following primary percutaneous coronary intervention predict large infarct size and left ventricular dysfunction in patients with ST-segment elevation acute myocardial infarction. , 2003, Atherosclerosis.

[19]  H. Katus,et al.  Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size , 2002, Heart.

[20]  T. Hackl,et al.  Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. , 2007, Journal of the American College of Cardiology.

[21]  A J Sinusas,et al.  Quantification of SPECT myocardial perfusion images: Methodology and validation of the Yale-CQ method , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.